Financial Advocates Investment Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$198K Sell
1,681
-507
-23% -$59.8K 0.02% 584
2025
Q1
$263K Sell
2,188
-7,751
-78% -$932K 0.02% 587
2024
Q4
$1.31M Sell
9,939
-20
-0.2% -$2.64K 0.07% 239
2024
Q3
$1.45M Buy
9,959
+994
+11% +$145K 0.08% 230
2024
Q2
$1.23M Buy
8,965
+6,959
+347% +$955K 0.08% 247
2024
Q1
$269K Sell
2,006
-5,720
-74% -$766K 0.02% 623
2023
Q4
$429K Buy
7,726
+4,220
+120% +$234K 0.03% 459
2023
Q3
$389K Sell
3,506
-2,499
-42% -$277K 0.03% 467
2023
Q2
$762K Sell
6,005
-285
-5% -$36.2K 0.05% 310
2023
Q1
$812K Sell
6,290
-557
-8% -$71.9K 0.06% 322
2022
Q4
$776K Buy
6,847
+2,834
+71% +$321K 0.06% 339
2022
Q3
$469K Sell
4,013
-524
-12% -$61.2K 0.04% 429
2022
Q2
$534K Sell
4,537
-5,885
-56% -$693K 0.04% 386
2022
Q1
$1.36M Sell
10,422
-3,278
-24% -$427K 0.09% 244
2021
Q4
$2.09M Buy
13,700
+3,819
+39% +$583K 0.13% 187
2021
Q3
$1.6M Sell
9,881
-4,179
-30% -$676K 0.11% 226
2021
Q2
$2.3M Buy
14,060
+376
+3% +$61.5K 0.15% 154
2021
Q1
$2.06M Buy
13,684
+1,139
+9% +$171K 0.15% 165
2020
Q4
$1.89M Sell
12,545
-1,867
-13% -$281K 0.13% 183
2020
Q3
$1.65M Buy
14,412
+1,272
+10% +$145K 0.14% 155
2020
Q2
$1.27M Buy
13,140
+6,106
+87% +$591K 0.12% 196
2020
Q1
$758K Sell
7,034
-1,293
-16% -$139K 0.11% 215
2019
Q4
$1M Sell
8,327
-549
-6% -$66.1K 0.11% 209
2019
Q3
$883K Sell
8,876
-999
-10% -$99.4K 0.1% 207
2019
Q2
$1.08M Sell
9,875
-1,506
-13% -$164K 0.12% 175
2019
Q1
$1.27M Buy
11,381
+4,653
+69% +$520K 0.16% 150
2018
Q4
$649K Buy
6,728
+1,791
+36% +$173K 0.09% 214
2018
Q3
$602K Buy
4,937
+113
+2% +$13.8K 0.07% 257
2018
Q2
$533K Sell
4,824
-129
-3% -$14.3K 0.06% 261
2018
Q1
$529K Buy
4,953
+11
+0.2% +$1.18K 0.07% 249
2017
Q4
$530K Buy
+4,942
New +$530K 0.07% 248